Broadcom: Healthy Results but Mum on Qualcomm
We estimate that Broadcom can raise its bid price as high as $85 per share and still find the acquisition to be quite accretive.
Broadcom Limited (AVGO) reported solid fiscal fourth-quarter earnings and provided investors with a forecast for the January quarter that was relatively in line with our expectations after factoring in the firm's recent acquisition of Brocade. Business conditions still appear quite healthy across most end markets, as the company will continue to reap the benefits of content gains within Apple's latest iPhone series. Longer term, with Brocade in the fold, we're encouraged that the company also raised a couple of its long-term profitability targets. We will maintain our $227 fair value estimate for narrow-moat Broadcom and shares still appear about 20% overvalued to us. That said, our valuation does not consider any potential contribution from Qualcomm, which the firm attempted to buy for $70 per share in early November. Management said little on the call about Qualcomm, but we continue to believe that such a deal would be materially accretive to Broadcom. We estimate that Broadcom can raise its bid price as high as $85 per share and still find the acquisition to be quite accretive. Along these lines, Broadcom's stock price in the $270 range appears reasonable to us only if it can in fact close the deal to buy Qualcomm, but looks pricey on a standalone basis.
Broadcom's revenue in the October quarter was $4.84 billion, up 9% sequentially and 17% year over year and ahead of the midpoint of the firm's previous guidance of $4.80 billion as discussed in early September. Wireless revenue was the bright spot, up 33% year over year and up 40% sequentially, again thanks to Broadcom's content gains within Apple's latest iPhones. Enterprise storage revenue appears to be cooling off, particularly for chips used in storage hard-disk drives, with sales down 12% sequentially but still up 15% year over year. Meanwhile, the firm's largest segment, Wired Infrastructure, saw sales rise 3% year over year but were down 3% sequentially.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Brian Colello does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.